EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Echinacoside as a Novel Ferroptosis Inducer in Hepatocellular Carcinoma: Mechanistic Insights from TP53/SLC7A11/GPX4 Pathway Modulation

Pei Wang, Jianhao Lin, Deqi Su iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Pei Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Sciences, School of Public Health, Xinjiang Medical University, Urumqi 830017, China. Hauptthemen laut MEDLINE: Ferroptosis, Tumor Suppressor Protein p53, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xinjiang Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the known antitumor properties of echinacoside (ECH), its specific role and mechanism in hepatocellular carcinoma (HCC) require in-depth exploration. Our study aimed to decipher the mechanism of ECH against HCC through a multi-disciplinary strategy. We first identified tumor protein p53 (TP53) as a key mediator and ferroptosis as a critical process, through network pharmacology and enrichment analyses. The direct interaction between ECH and TP53 was validated by molecular docking and dynamics simulations. In vitro assessments demonstrated that ECH suppresses HCC proliferation by activating ferroptosis, marked by increased intracellular Fe2+, lipid peroxidation (LPO), and malondialdehyde (MDA), alongside reduced glutathione (GSH). The ferroptosis inhibitor ferrostatin-1 notably attenuated ECH’s effects, confirming ferroptosis as the primary mode of cell death. Further mechanistic investigation revealed that ECH acts through the TP53/solute carrier family 7 member 11(SLC7A11)/glutathione peroxidase 4(GPX4) pathway. These results collectively identify ECH as a promising ferroptosis-inducing agent for HCC therapy via TP53 activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisTumor Suppressor Protein p53Liver NeoplasmsCarcinoma, HepatocellularGlycosidesPhospholipid Hydroperoxide Glutathione PeroxidaseHumansMolecular Docking SimulationSignal TransductionCell Line, TumorCell ProliferationLipid PeroxidationAmino Acid Transport System y+

Stichwörter der Autor:innen

echinacosideferroptosishepatocellular carcinomanetwork pharmacology

Substanzen

Tumor Suppressor Protein p53GlycosidesechinacosidePhospholipid Hydroperoxide Glutathione PeroxidaseSLC7A11 protein, humanTP53 protein, humanAmino Acid Transport System y+

Autor:innen und Institutionen

  • Institute of Medical Sciences, School of Public Health, Xinjiang Medical University, Urumqi 830017, China.

ORCID-Profile: Deqi Su

Förderung

  • Xinjiang Medical University

Zitieren

APA

Wang, P., Lin, J., & Su, D. (2025). Echinacoside as a Novel Ferroptosis Inducer in Hepatocellular Carcinoma: Mechanistic Insights from TP53/SLC7A11/GPX4 Pathway Modulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010411

Vancouver

Wang P, Lin J, Su D. Echinacoside as a Novel Ferroptosis Inducer in Hepatocellular Carcinoma: Mechanistic Insights from TP53/SLC7A11/GPX4 Pathway Modulation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010411

BibTeX
@article{Wang2025,
  author = {Wang, Pei and Lin, Jianhao and Su, Deqi},
  title = {Echinacoside as a Novel Ferroptosis Inducer in Hepatocellular Carcinoma: Mechanistic Insights from TP53/SLC7A11/GPX4 Pathway Modulation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010411}
}
Kostenlos starten →